Trial record 1 of 1 for:    Phenylbutyrate Development for Huntington's Disease
Previous Study | Return to List | Next Study

Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)

This study has been completed.
Sponsor:
Collaborators:
HP Therapeutics Foundation
Massachusetts General Hospital
Columbia University
University of Iowa
University of California, San Diego
University of Kansas Medical Center
University of Alabama at Birmingham
Johns Hopkins University
Information provided by:
University of Rochester
ClinicalTrials.gov Identifier:
NCT00212316
First received: September 19, 2005
Last updated: August 14, 2012
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2006
  Estimated Primary Completion Date: No date given